AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$1.12
−6.67%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-86.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 20, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 29,036 | $1.40 |
| Jan 20, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 7,868 | $1.29 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 20, 2026